what is the fda deadline for glp-1 drugs New project announcement: HHS‑OIG taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our The Landscape Of GLP-1 Receptor
Description
Individuals interested in supporting gut microbiome balance and metabolic wellness may consider targeted probiotic supplements

Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the -cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus

To support our research and testing, we may earn a commission if you sign up or purchase through certain links on this page at no additional cost to you

Importantly, large-scale randomized trials, meta-analyses, and observational studies suggest that GLP-1RAs do not significantly increase AKI risk and may even confer renal benefits in high-risk populations

Earlier this year, Blue Cross Blue Shield said five GLP-1 drugs now account for nearly 20% of its pharmacy spend.
Support for weight management goals
